This section shows a general overview of information for the selected study (COSU identifier) or publication (COSP identifier). Studies may have been performed by the Sanger Institute Cancer Genome Project, or imported from the ICGC/TCGA. You can see more information on the help pages.
- Reference
- Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma.
- Paper ID
- COSP46197
- Authors
- Affiliation
- Institute of Pathology, University Clinic of Heidelberg, Heidelberg, Germany.
- Journal
-
Hepatology (Baltimore, Md.), 2019
ISSN: 1527-3350
PMID: 30615206 (view at PubMed or Europe PMC) - Abstract
- Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver cancer. It is defined by cholangiocytic differentiation and has poor prognosis. Recently, epigenetic processes have been shown to play an important role in cholangiocarcinogenesis. We here performed an integrative analysis on 52 iCCAs using both genetic and epigenetic data with specific focus on DNA methylation components. We found recurrent IDH1 and IDH2 (28%) gene mutations, recurrent arm-length copy number alterations (CNAs), and focal alterations such as deletion of 3p21 or amplification of 12q15 which affect BAP1, PBRM1, and MDM2. DNA methylome analysis revealed excessive hypermethylation of iCCA, mainly affecting bivalent genomic regions marked with both active and repressive histone modifications. Integrative clustering of genetic and epigenetic data identified four iCCA subgroups with prognostic relevance further designated as IDH, high (H), medium (M) and low (L) alterations group. The IDH group comprised all samples with IDH1 or IDH2 mutations and showed, together with the H group, a highly disrupted genome, characterized by frequent deletions of chromosome arms 3p and 6q. Both groups showed excessive hypermethylation with distinct patterns. The M group showed intermediate characteristics regarding both genetic and epigenetic marks, whereas the L group exhibited few methylation changes and mutations and a lack of CNAs. Methylation-based latent component analysis of cell-type composition identified differences between these four groups. Prognosis of the H and M groups was significantly worse than that of the L group. CONCLUSION: Using an integrative genomic and epigenomic analysis approach, we identified four major iCCA subgroups with widespread genomic and epigenomic differences and prognostic implications. Furthermore, our data suggest differences in the cell-of-origin of the iCCA subtypes. This article is protected by copyright. All rights reserved.
- Paper Status
- Curated
- Genes Analysed
- 26
- Mutated Samples
- 13
- Total No. of Samples
- 36
